10/30/2026
Breast Cancer Awareness Month often focuses on screening and early detection. What happens after an abnormal finding matters just as much.
Right now, there is a nationwide shortage of stereotactic breast biopsy needles, and the FDA expects it to continue through the first quarter of 2027. Some radiology teams are adjusting equipment, biopsy approach, or imaging guidance when clinically appropriate.
When the procedure changes, the documentation should reflect it, including the device, technique, and guidance actually used.
For a woman waiting to learn whether an abnormality is cancer, that biopsy may be one of the most important moments of her life. The teams adapting to this shortage are working to make sure that moment comes without delay.
Every step of her journey matters. To the radiology teams that keep care moving through every challenge, thank you.